KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Change in Accured Expenses (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Change in Accured Expenses for 15 consecutive years, with -$40.3 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 9545.93% to -$40.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$24.6 million through Dec 2025, down 63.61% year-over-year, with the annual reading at -$24.6 million for FY2025, 63.61% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$40.3 million at Supernus Pharmaceuticals, down from $3.5 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $57.4 million in Q2 2021, with the low at -$47.1 million in Q4 2023.
  • Average Change in Accured Expenses over 5 years is -$2.6 million, with a median of $505000.0 recorded in 2024.
  • The sharpest move saw Change in Accured Expenses skyrocketed 2433.83% in 2022, then plummeted 9545.93% in 2025.
  • Over 5 years, Change in Accured Expenses stood at -$1.4 million in 2021, then surged by 2433.83% to $31.6 million in 2022, then tumbled by 249.03% to -$47.1 million in 2023, then skyrocketed by 99.11% to -$418000.0 in 2024, then tumbled by 9545.93% to -$40.3 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at -$40.3 million, $3.5 million, and $10.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.